FDA issued a Warning Letter to Amgen, Inc. on 1/27/2014 for a previous inspection.
483 Amgen May 2017

483 Amgen May 2017

Laura Fontan FDA$119.00 - Available Now

FDA investigators audited the Amgen - Thousand Oaks, CA, United States facility and issued inspectional observations (via FDA 483) on 16 May 2017.

Product details

  • Category: Human Drugs
  • Inspection end: 16 May 2017
  • Location: Thousand Oaks, United States
  • FEI: 2026154
Add To Cart